Chunghwa Chemical Synthesis & Biotech Co., Ltd. — Investor Relations & Filings
Chunghwa Chemical Synthesis & Biotech Co., Ltd. (CCSB) is a specialized manufacturer of Active Pharmaceutical Ingredients (APIs) with a history dating back to 1964. The company focuses on the research, development, and large-scale production of high-quality APIs, particularly in the therapeutic areas of oncology, antifungal treatments, and immunosuppressants. CCSB offers a broad service portfolio that includes cGMP-compliant contract manufacturing and toll manufacturing. By leveraging advanced chemical synthesis and biotechnology platforms, the company provides tailored solutions to global pharmaceutical partners. CCSB adheres to rigorous international quality standards and environmental, health, and safety protocols, ensuring the reliable supply of critical medicinal components for the global healthcare market.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公告本公司董事會決議配息基準日 | 2023-06-27 | Chinese | |
| 112年6月19日內部人設質解質 | 2023-06-20 | Chinese | |
| 111年企業ESG資訊揭露 | 2023-06-19 | Chinese | |
| 112年年報及股東會資料 — 2023_1762_20230530FE2.pdf | 2023-06-13 | Chinese | |
| 112年年報及股東會資料 — 2023_1762_20230530F02.pdf | 2023-06-13 | Chinese | |
| 112年年報及股東會資料 — 2023_1762_20230530FE1.pdf | 2023-06-13 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 33465481 | 公告本公司董事會決議配息基準日 | 2023-06-27 | Chinese | ||
| 33465485 | 112年6月19日內部人設質解質 | 2023-06-20 | Chinese | ||
| 33465490 | 111年企業ESG資訊揭露 | 2023-06-19 | Chinese | ||
| 33469015 | 112年年報及股東會資料 — 2023_1762_20230530FE2.pdf | 2023-06-13 | Chinese | ||
| 33469014 | 112年年報及股東會資料 — 2023_1762_20230530F02.pdf | 2023-06-13 | Chinese | ||
| 33469013 | 112年年報及股東會資料 — 2023_1762_20230530FE1.pdf | 2023-06-13 | Chinese | ||
| 33469012 | 112年年報及股東會資料 — 2023_1762_20230530F01.pdf | 2023-06-13 | Chinese | ||
| 33465501 | 112年5月背書保證與資金貸與 | 2023-06-09 | Chinese | ||
| 33465495 | 112年5月營業收入 | 2023-06-09 | Chinese | ||
| 33465511 | 112年05月內部人持股異動(事後) | 2023-06-06 | Chinese | ||
| 33465505 | 112年05月董事會成員及持股 | 2023-06-06 | Chinese | ||
| 33465514 | 公告本公司112年股東常會重要決議事項 | 2023-05-30 | Chinese | ||
| 33465519 | 112年第1季海外子公司投資 | 2023-05-15 | Chinese | ||
| 33465541 | 112年第1季權益變動表 | 2023-05-15 | Chinese | ||
| 33465535 | 112年第1季現金流量表 | 2023-05-15 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Chunghwa Chemical Synthesis & Biotech Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/51917/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=51917 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=51917 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=51917 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 51917}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Chunghwa Chemical Synthesis & Biotech Co., Ltd. (id: 51917)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.